tiprankstipranks
Trending News
More News >
C4 Therapeutics (CCCC)
NASDAQ:CCCC
US Market
Advertisement

C4 Therapeutics (CCCC) Revenue

Compare
511 Followers

C4 Therapeutics Revenue

C4 Therapeutics had a revenue of 7.24M in the quarter ending Mar 31, 2025, with 39.81%. This bring the company's revenue in the last twelve months to 39.78M, Decreased 11.80%. In the fiscal year ending Dec 31, 2024, C4 Therapeutics had annual revenue of 35.58M with 71.44% growth.
Revenue (ttm)
39.78M
Revenue Growth
98.56%
P/S Ratio
4.03
Revenue/Employee
$323,491
Employees
110
Market Cap
$143.43M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
35.58M14.83M+71.44%
Dec 31, 2023
20.76M-10.34M-33.25%
Dec 31, 2022
31.10M-14.69M-32.08%
Dec 31, 2021
45.78M12.59M+37.93%
Dec 31, 2020
33.20M11.81M+55.25%
Dec 31, 2019
21.38M2.02M+10.42%
Dec 31, 2018
19.36M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis